TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/22 21:02 | 11/8/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | M.d | 0 | 0.00 | 0 | 6 | 27 | 26 | D | ||||||||||||||
11/10/22 21:02 | 11/9/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | S.dm | -2 | 1.03 | 0 | -2 | -6 | 26 | D | ||||||||||||||
8/10/22 18:54 | 8/8/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | M.d | 0 | 0.00 | 0 | 6 | 34 | 22 | D | ||||||||||||||
8/10/22 18:54 | 8/9/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | S.d | -4 | 2.53 | 0 | -2 | -7 | 22 | D | ||||||||||||||
5/11/22 21:42 | 5/9/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | M.d | 0 | 0.00 | 0 | 6 | 44 | 18 | D | ||||||||||||||
5/11/22 21:42 | 5/10/22 | BDSX | Biodesix Inc | DE | Health | Health | Medical Laboratories | Georgantas Robert William III | CO | O | Chief Sc | S.d | -4 | 1.83 | 0 | -2 | -10 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |